MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$16,990M
Net Income
$3,613M
Net Profit Margin
21.27%
EPS
$2.03
Unit: Million (M) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenues
16,990
15,002
16,618
15,776
Cost of products sold
4,291
4,218
4,552
5,304
Selling, general and administrative
3,632
3,578
3,895
3,569
Research and development
2,344
2,472
2,579
2,319
Acquired ipr&d and milestones
291
744
1,265
2,680
Other operating income
0
-
217
0
Total operating costs and expenses
10,558
11,012
12,074
13,872
Operating earnings
6,432
3,990
4,544
1,904
Interest expense, net
-679
-645
-655
-667
Net foreign exchange loss
-
-
-11
-20
Other expense, net
-1,475
-2,306
-1,210
-503
Earnings before income tax expense
4,278
1,039
2,668
714
Income tax expense
662
342
853
526
Net earnings
3,616
697
1,815
188
Net earnings attributable to noncontrolling interest
3
2
-1
2
Net earnings attributable to abbvie inc
3,613
695
1,816
186
Basic EPS
2.04
0.39
1.025
0.1
Diluted EPS
2.03
0.39
1.022
0.1
Basic Average Shares
1,769,000,000
1,770,000,000
1,771,000,000
1,769,000,000
Diluted Average Shares
1,771,000,000
1,774,000,000
1,777,000,000
1,772,000,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net revenues
$16,990M
(10.16%↑ Y/Y)
Operating earnings
$6,432M
(31.43%↑ Y/Y)
Total operating costs
and expenses
$10,558M
(0.28%↑ Y/Y)
Earnings before income
tax expense
$4,278M
(175.29%↑ Y/Y)
Other expense, net
-$1,475M
(44.11%↑ Y/Y)
Interest expense, net
-$679M
(-0.15%↓ Y/Y)
Cost of products sold
$4,291M
(-1.27%↓ Y/Y)
Selling, general and
administrative
$3,632M
(11.65%↑ Y/Y)
Research and development
$2,344M
(10.00%↑ Y/Y)
Acquired ipr&d and
milestones
$291M
(-64.64%↓ Y/Y)
Net earnings
$3,616M
(284.27%↑ Y/Y)
Income tax expense
$662M
(7.99%↑ Y/Y)
Net earnings
attributable to abbvie inc
$3,613M
(285.18%↑ Y/Y)
Net earnings
attributable to...
$3M
(0.00%↑ Y/Y)
Buy us a coffee
ABBV_BIG copy-svg
AbbVie Inc. (ABBV)
ABBV_BIG copy-svg
AbbVie Inc. (ABBV)
Show more